B.A. Schrock Wealth Management, Inc.’s Vertex Pharmaceuticals VRTX Stock Holding History

B.A. Schrock Wealth Management, Inc.’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$476K	Buy	+939	New	+$481K	0.17%	93

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

MLL

Moody Lynn & Lieberson Boston, Massachusetts $1.93B AUM 20.85% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

B.A. Schrock Wealth Management, Inc.'s VRTX Position: Q3 2026 in Review

B.A. Schrock Wealth Management, Inc. opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 939 shares worth $476K. The stake represents 0.17% of the portfolio and ranks #93 among its holdings.

209 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

B.A. Schrock Wealth Management, Inc. held 939 shares of Vertex Pharmaceuticals worth $476K as of Q3 2026.
Vertex Pharmaceuticals was a new B.A. Schrock Wealth Management, Inc. position in Q3 2026.
Vertex Pharmaceuticals made up 0.17% of B.A. Schrock Wealth Management, Inc.'s portfolio in Q3 2026, its #93 holding.
209 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on B.A. Schrock Wealth Management, Inc.'s 13F filing for Q3 2026, filed 15 Oct 2026.